EU medicines agency not suited to perform device evaluations, says commission report
This article was originally published in RAJ Devices
A European Commission-mandated report on the performance of the European Medicines Agency points out that the agency, “at this stage, is not suited to perform [the] evaluation of all medical devices”1,2.
You may also be interested in...
Executive Summary: The European pharma industry federation believes the advice provided in the updated draft EU guideline on additional risk minimization measures is far too detailed, resulting in a lack of focus, information overlap and confusion.
At its latest meeting in June, the International Council for Harmonisation agreed on new topics that could benefit from harmonized advice and took note of progress made on drafting and finalizing quality, safety and multidisciplinary guidelines.
COVID-19 is driving changes to how clinical trials are being conducted in the US, with 44% of respondents who participated in a recent survey saying they have adapted or plan to become decentralized in coming months.